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A B S T R A C T
We experienced a case of Kounis syndrome with cardiopulmonary arrest and severe coronary spasm. A
70-year-old man with cardiac pacemaker and chronic dialysis was treated for angina pectoris of the right
coronary artery. After diagnostic coronary angiography of the right coronary artery, optical coherence
tomography was performed with contrast medium and low-molecular-weight dextran. The patient’s
blood pressure unexpectedly dropped to 40 mmHg and erythema of the breast was noted.
Electrocardiogram showed remarkable ST elevation in II, III, aVF leads. Coronary angiography showed
total occlusion of the proximal right coronary artery. Although intracoronary infusion of sodium nitrate
did not dilate the coronary artery promptly, coronary balloon angioplasty recovered the artery ﬂow.
Since severe anaphylaxis-related shock was contemplated, methyl prednisolone and epinephrine were
administered intravenously. We could not introduce percutaneous cardiopulmonary support due to
kinking of the vein. After 1 hour of cardiopulmonary resuscitation with frequent ventricular ﬁbrillation
and direct current shock, the sinus rhythm and blood pressure recovered. Following 2 months of
intensive care treatment for other complications, including infection, the patient was discharged from
hospital without any residual disability.
<Learning objective: An anaphylactic reaction is one of the causes of sudden deterioration of a patient’s
condition observed during interventional procedures. Kounis syndrome is a rare and not yet well known
important concept that deals with the reaction. Therefore, we report a severe case of Kounis syndrome
with cardiopulmonary arrest.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Kounis syndrome is an anaphylactic reaction that causes either
coronary spasm (type I) or acute coronary syndrome due to plaque
rupture or coronary erosion (type II) [1,2]. Usually a skin reaction
and reduced blood pressure are accompanying symptoms. We
report a case with an abrupt and prolonged cardiac arrest due to
severe coronary spasm and reduction in blood pressure by vessel
dilatation of the whole body after intracoronary infusion of low-
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A 70-year-old man with cardiac pacemaker was admitted to our
hospital for percutaneous coronary intervention (PCI) of the right
coronary artery (RCA).
He was admitted to the hospital 1 month before the present
admission with dyspnea and diagnosed with complete atrioven-
tricular block with a heart rate of 33/min. He had diabetes mellitus
and hypertension and was administered several drugs. Cardiac
echocardiography showed no wall motion abnormality with
ejection fraction of 83% as well as abnormal relaxation (E/A ratio
0.79) and mildly elevated end-diastolic pressure (E/E0 15.8) and
pulmonary systolic pressure (48 mmHg). Before DDD pacemaker
implantation, coronary angiography was performed and 75%
diameter stenosis at the distal RCA was detected. No allergic
reaction was observed after coronary angiography (CAG). He reserved.
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implantation and was discharged from hospital 1 month prior to
the present admission. His prescription medications were azilsar-
tan 20 mg, amurodipine 5 mg, glimepiride 1 mg, linagliptin 5 mg,
and metformin 500 mg per day. He showed no abnormal ﬁnding on
physical examination. Blood pressure was 138/64 mmHg and the
heart rate was 86/min. The electrocardiogram (ECG) showed
pacemaker rhythm (A sensing and V pacing, Fig. 1A). The white
blood cell count was 5610/mL. The red blood cell count was
454  104/mL. Platelet count was 16.2  104/mL. The proportion of
eosinophils was 2.6% and was less than 2% during hospitalization.
IgE level was not measured. Blood urea nitrogen level was 26.9 mg/
dL and serum creatinine level was 0.77 mg/dL. Na, K, and Cl levels
were 142, 4.4 and 107 mEq/L, respectively. Blood glucose level was
158 mg/dL and hemoglobin A1c was 7.9% indicating poor diabetic
control. Other blood data showed no abnormalities. Chest
radiography showed cardiothoracic ratio of 46%. On the second
day, PCI was performed. A 6Fr Launcher SAL1.5SH (Medtronic, Inc.,
Minneapolis, MN, USA) guiding catheter was engaged for the RCA.
CAG of the RCA was performed once in the left anterior oblique
position (Fig. 2A). A guide wire was introduced into the RCA and
optical coherence tomography (OCT, St Jude Medical, Inc., St Paul,
MN, USA) was performed. A mixture of contrast media and low-
molecular weight-dextran (1:1, 18 mL) was injected into the
RCA for removal of blood. Suddenly, the patient complained
of bilateral arm pain and dyspnea. Systolic blood pressure dropped
to 40 mmHg. Broad redness on the surface of his breast was
observed. ECG showed remarkable ST elevation at II, III, aVF leads
and ST depression at V1-4 leads (Fig. 1B). His consciousness
became Japan coma scale 300 and breathing stopped. Subsequent-
ly, cardiopulmonary resuscitation was performed. Anaphylactic
shock was assumed and 125 mg methyl prednisolone was injectedFig. 1.
Electrocardiogram during percutaneous coronary intervention. (A) Before cor
Ventricular ﬁbrillation. (D) Recovery to sinus rhythm.intravenously and 0.5 mg epinephrine was injected intramuscu-
larly followed by intubation. CAG showed total occlusion at the
proximal RCA (Fig. 2B). We did not perform CAG of the left
coronary artery because of cardiopulmonary arrest and risk of
contrast medium allergy. Since intracoronary infusion of 2.5 mg
isosorbide dinitrate did not dilate the coronary artery promptly, a
percutaneous coronary balloon angioplasty was performed with a
3-mm balloon catheter (Fig. 2C). After the procedure, both of the
RCA coronary ﬂow and the ST elevation at II, III, and aVF were
regained (Fig. 2D). However, cardiac arrest continued and 1 mg
epinephrine was administered intravenously twice with a 4-min
interval. Repetitive ventricular ﬁbrillation occurred and biphasic
direct current (DC) shocks with 150 J were performed (Fig. 1C). We
could not introduce percutaneous cardiopulmonary support
(PCPS) due to kinking of the left iliac vein. Moreover, we did not
introduce intra-aortic balloon pump (IABP) because of prolonged
introduction of PCPS. After 1-hour cardiopulmonary resuscitation
with frequent ventricular ﬁbrillation and DC shocks, a sinus
rhythm and systolic blood pressure of 100 mmHg was recovered
(Fig. 1D). OCT showed a partial lipid-rich plaque at the spastic site
and ﬁbrous plaques at other sites (Fig. 3). Tryptase on the day of PCI
was 39.1 mg/L and the next day was 23.8 mg/L (normal range 2.6–
9 mg/L) (Fig. 4). Kounis syndrome was diagnosed. Troponin T level
was 4.99 ng/mL (N < 0.014) on day 3. Maximal creatine kinase (CK)
level was 20,230 IU/L and maximal CK-MB level was 227 IU/L on
day 4. There was a large discrepancy between these values mainly
because of vigorous chest compression and electrical deﬁbrillation.
The causal antigen was considered as either low molecular dextran
or contrast media. The drug-induced lymphocyte stimulation test
(DLST) was negative for either agent and for xylocaine. The patient
was complicated by bacteremia and was treated with antibiotics.
After intensive care for treatment of the infection and cardiaconary angiography. (B) Occurrence of ST change at II, III, aVF, and V1-4 leads. (C)
Fig. 2.
Coronary angiography (CAG) and percutaneous coronary intervention. (A) CAG before optical coherence tomography. (B) Severe coronary spasm and coronary
obstruction at the proximal right coronary artery (RCA). (C) Balloon dilatation was performed ﬁve times from distal to proximal RCA. (D) Coronary ﬂow recovered.
Minor ﬂap was observed at the former stenotic lesion.
Fig. 3.
Optical coherence tomography images before occurrence of the symptoms. (A) Around the spasm site proximal to the stenosis. A ﬁbrous plaque and lipid-rich
plaque (6 to 9 o’clock) overlapped. (B) Stenotic site. A ﬁbrous plaque and hard plaque overlapped. (C) A ﬁbrous plaque was observed distal to the stenosis.
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Fig. 4.
Progress of hospitalization. CK is indicated with a solid line. CK-MB is shown with dots. Consciousness of the patient is shown with a dotted line. CK, creatine
kinase; JCS, Japan Coma Scale; PCI, percutaneous coronary intervention; mPSL, methyl prednisolone; DIC, disseminated intravascular coagulation.
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hospital to rehabilitate the weakened muscles of the legs. Before
discharge, ECG showed no abnormal Q and the rhythm was A
sensing and V pacing. Echocardiography showed left ventricular
diffuse mild hypokinesis with an ejection fraction of 57.5%. Neither
ﬁnding indicated previous myocardial infarction.
Discussion
The ﬁrst reports of cardiovascular diseases with allergic
reaction and anaphylaxis were published more than 60 years ago
[3,4]. Kounis syndrome was ﬁrst reported by NG Kounis in
1991[1]. It consists of three types of responses: type I, coronary
spasm; type II, acute myocardial infarction due to coronary
erosion; and type III, stent thrombosis due to allergic inﬂamma-
tion. All conditions are associated with mast-cell activation in the
setting of hypersensitivity and anaphylactic reaction. Histamine
is one of the representative mediators [2]. The increase in
tryptase level is another marker of on-going allergic reaction
[2]. Tryptase level was high in our case on the day of the
occurrence. Different drugs and agents such as latex, food, and
contrast media are reported to be the causes of this reaction
[2]. It is reported that tryptase level is high in acute coronary
syndrome (ACS) cases [5] with tryptase levels reaching
11.13  1.55 mg/L. Tryptase level in our case was 39.1 mg/L and
was much higher than that in ACS cases. Since the cut-off value of
tryptase for the diagnosis of Kounis syndrome has not been clearly
determined, elevation of tryptase levels is supportive for the
diagnosis of Kounis syndrome [2]. The accurate incidence of Kounis
syndrome is not known, but many clinical case reports with various
allergens have been published [2].
In our case, immediately after performing OCT, bradycardia and
shock occurred with precordial erythema. CAG showed severe
diffuse RCA spasm with total obstruction. Catheter-induced spasm
sometimes occurs near the catheter tip. In our case, spasm
occurred at the proximal RCA. Therefore, the possibility of
catheter-induced spasm was low. OCT wire-induced rare coronary
spasm has also been reported [6]. It recovered by nitrate injection.
It is difﬁcult to completely deny mechanically stimulated coronary
spasm. However, it is impossible to explain the severe shock state.
Although the OCT showed a lipid-rich plaque at the spastic site, it is
difﬁcult to determine the causal relationship with Kounis
syndrome. We could not perform left coronary angiography
because the patient’s circulatory condition deteriorated andrequired treatment. The possibility of left coronary artery spasm
was low given the ﬁnding of ST elevation of II, III, and aVF and ST
depression of V1-4. However, the possibility of a mild spasm of the
left coronary artery could not be excluded. After 1 hour of
cardiopulmonary resuscitation (CPR), sinus rhythm and blood
pressure ﬁnally recovered. We could not introduce PCPS or IABP.
This may be one factor for the longer CPR required. However, a
larger factor contributing to the delayed recovery may be that
epinephrine and steroid treatment were not immediately active for
anaphylactic shock. Repetitive ventricular ﬁbrillation may be
another factor of delayed recovery from the shock.
As for the cause of Kounis syndrome in our case, we speculate
that the low-molecular-weight dextran may have been the
causative agent. Contrast medium and xylocaine are other
candidates, although the previous CAG and the ﬁrst shot of
contrast medium on the same day did not cause an anaphylactic
reaction. Although DLST tests of these materials were negative,
low-molecular-weight dextran was the most likely agent because
it had been administered to this patient for the ﬁrst time and
Kounis syndrome occurred immediately after its administration.
There have been several reports describing how low-molecular-
weight dextran (dextran 40) caused coronary spasm before Kounis
syndrome was advocated [7,8]. In addition, a report has also
suggested that Kounis syndrome occurred due to dextran 40
[9]. Although it is rare that low-molecular-weight dextran could
cause Kounis syndrome, the incidence rate may increase in the
future because of its frequent usage in OCT for PCI. Thus, we should
be attentive to the possible occurrence of Kounis syndrome during
PCI procedure.
Treatment of Kounis syndrome is often difﬁcult because both
cardiac and allergic symptoms are to be treated simultaneously
and rapidly. In patients with the type I variant, the use of
hydrocortisone 1–2 mg/kg/d intravenously and H2 antihistamines,
such as diphenhydramine (1–2 mg/kg) and ranitidine (1 mg/kg),
are recommended to reduce allergic symptoms. The use of calcium
channel blockers and nitrates may abolish vasospasm. However,
these drugs may cause hypotension and deteriorate the circulatory
condition. Nicorandil may be another good candidate to treat
Kounis syndrome because it can dilate the coronary artery without
lowering blood pressure. In our case, given the urgency of the
severe condition, coronary artery dilatation by balloon catheter
was also successful and may represent a treatment option for
severe Kounis syndrome. Epinephrine is the drug of choice for
anaphylaxis. It has been described that epinephrine administration
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recommended to administer epinephrine intramuscularly with at
a dose of 0.2–0.5 mg (1:1000). After cardiopulmonary arrest, 1 mg
of epinephrine intravenously is required according to the advanced
life support guidelines. It is important to be alert for the occurrence
of Kounis syndrome and to treat both allergy and coronary lesions
immediately.
We experienced a rare case of Kounis syndrome after CAG in
OCT procedures. We must be more attentive to the occurrence of
the syndrome during OCT with low-molecular-weight dextran.
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